Greg Cavers - 29 Sep 2026 Form 4 Insider Report for Helus Pharma Inc. (HELP)

Reporting relationship: Chief Financial Officer
Issuer ticker: HELP
Reported as of: 29 Sep 2026
Net transaction value: +$38,730
SEC form: 4
Accepted by SEC: 01 Oct 2026, 20:13:59 UTC
Source filing: View source filing
Reporting owner signature: /s/ Greg Cavers

Key filing fact

Greg Cavers filed Form 4 for Helus Pharma Inc. (HELP) on 01 Oct 2026.

Key facts

This page summarizes Greg Cavers's Form 4 filing for Helus Pharma Inc. (HELP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 Oct 2026, 20:13.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$38,730.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002116548 Primary reporting owner

Cavers Greg

Relationship: Chief Financial Officer
Address: C/O HELUS PHARMA INC., 100 KING STREET W., SUITE 5600, TORONTO, ONTARIO, CANADA
Signature: /s/ Greg Cavers
Signature date: 01 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HELP transaction

Common Shares

Purchase

Transaction value: $38,730
Shares: +3,000
Change %
Price: $12.91
Shares after: 3,000
Date: 29 Sep 2026
Ownership: Held by spouse
Footnotes: F1

HELP holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 125,937
Date: 29 Sep 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Converted from Canadian purchase price of C$18.3157 using an exchange rate of C$1.4188 = US$1.00.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .